AzurRx BioPharma adds two additional clinical trial sites in Poland
AzurRx BioPharma has added two additional clinical trial sites in Poland to reduce any potential...
AzurRx BioPharma has added two additional clinical trial sites in Poland to reduce any potential...
Cyxone has announced the screening of the first participant in the Phase II clinical trial...
Cyxone is set to initiate a Phase II clinical trial with Rabeximod in moderate Covid-19...
WPD Pharmaceuticals and CNS Pharmaceuticals are set to initiate a Phase I clinical trial for...
Moleculin has undertaken and enrolled patients in two anti-cancer clinical trials in Poland.
Orion Biotechnology Canada has completed the acquisition of K2Biomedical for an undisclosed sum.
US-based biopharmaceutical company Ultragenyx Pharmaceutical Inc has announced a public offering of shares of its...